Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169530 | SCV000221009 | likely pathogenic | Niemann-Pick disease, type C1 | 2015-01-06 | criteria provided, single submitter | literature only | |
Invitae | RCV000169530 | SCV000963974 | likely pathogenic | Niemann-Pick disease, type C1 | 2020-12-04 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in several individuals affected with Niemann-Pick disease (PMID: 10521290, 16126423, 17160617, 25236789). ClinVar contains an entry for this variant (Variation ID: 189117). This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with glutamine at codon 934 of the NPC1 protein (p.Arg934Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. |
Centre for Mendelian Genomics, |
RCV000169530 | SCV001367846 | pathogenic | Niemann-Pick disease, type C1 | 2019-02-18 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PS3,PM2,PP3. |